ABU DHABI/WAM On behalf of President His Highness Sheikh Mohamed bin Zayed Al Nahyan, H.H. ...
Read More »Bayer, J&J’s drug Xarelto fails trial by ‘Mariner’
Bloomberg Bayer AG and Johnson & Johnson’s blood-thinning drug Xarelto didn’t prevent clotting in high-risk patients after they were released from the hospital, a setback for one of the manufacturers’ best-selling drugs. About 12,000 medically ill patients at increased risk of blood clotting took part in the trial, known as the Mariner study. The results were presented at the European ...
Read More »